Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
China Pharma Holdings, Inc. Reports Fiscal Year 2018 Financial Results 2019-03-29 18:00
The Geneva Association: Ping An Good Doctor is Improving the Quality of China's Medical Services 2019-03-29 14:46
Luye Pharma's Rykindo® Expected to Be the First Chinese Innovative Drug to Receive U.S. FDA Approval 2019-03-29 11:48
Transcenta Holding Announces Licensing Agreement with Lilly 2019-03-29 08:30
China SXT Pharmaceuticals, Inc. Announces Financial Results for the Six Months Ended September 30, 2018 2019-03-28 18:30
WAT Medical Interviewed by NHK, Japan's National Broadcasting Organization 2019-03-27 21:30
WuXi STA's New Drug Product Manufacturing Facility Passes First European MPA GMP Inspection 2019-03-27 14:00
Health2Sync, CTBC Bank and Bitmark Launch World's First Diabetes Data Trust 2019-03-26 21:01
GCAM Adds New Plasma Collection Center 2019-03-26 12:05
Dr Thomas Ramdahl Joins Clarity Pharmaceuticals' Board 2019-03-26 08:30
VolitionRx Limited to Present at Conferences in March & April 2019 2019-03-25 20:40
CStone appoints three distinguished oncology leaders Drs. Paul A. Bunn, Jr., Elizabeth M. Jaffee and Richard S. Finn to its Scientific Advisory Board 2019-03-25 15:14
WuXi AppTec Reports Strong 2018 Annual Results 2019-03-22 20:47
CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009) 2019-03-21 21:32
Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials 2019-03-21 18:21
Samsung BioLogics Wins 2019 CMO Leadership Awards in All Six Core Categories Three Years in a Row 2019-03-21 13:42
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody 2019-03-21 07:20
WuXi Biologics Receives EMA GMP Certificates 2019-03-20 08:07
I-Mab Biopharma and MorphoSys Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma 2019-03-20 05:05
I-Mab Biopharma Announces Dosing of First Subject in Phase 1 Clinical Trial of Anti-GM-CSF Monoclonal Antibody TJM2 in the United States 2019-03-19 18:00
1 225 226 227 228 229 431